Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This post-operative care regimen is a pharmacological combination consisting of the antibiotic amoxicillin, the analgesic and antipyretic sodic dipyrone (metamizole), and the antiseptic chlorhexidine. Developed as a standardized protocol for a clinical trial led by Renato Correa Viana Casarin, the regimen is designed to manage the recovery of patients with edentulous jaws undergoing dental implant surgery. Amoxicillin (500 mg) is administered to prevent bacterial infections by inhibiting cell wall synthesis. Sodic dipyrone (500 mg) provides systemic pain relief and fever reduction, while 0.12% chlorhexidine mouthwash is used for local decontamination of the surgical site. The combination aims to optimize the environment for osseointegration by minimizing inflammation and microbial load during the critical early healing phase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amoxicillin + dipyrone + chlorhexidine.